Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Lexagene Holdings Inc LXXGQ

Lexagene Holdings Inc. is a molecular diagnostics company engaged in researching, developing and commercializing automated genetic analyzer devices in clinical and life science industries. The Company is focused on developing molecular diagnostic systems for pathogen detection and genetic testing for other molecular markers for on-site rapid testing in veterinary diagnostics, and for use in open-access markets such as food and water safety, clinical research, agricultural testing and biodefense. The Company's MiQLab System is an automated, open-access molecular diagnostic system for pathogen detection, allowing users to test for multiple pathogens onsite, returning results in approximately 2 hours. Its MiQLab System is an automated, multiplexing polymerase chain reaction (PCR)-based system designed for syndromic testing in human clinical diagnostics and veterinary diagnostics, as well as food safety testing, and open-access custom testing markets.


GREY:LXXGQ - Post by User

Comment by Sandman852on Oct 19, 2021 3:17pm
262 Views
Post# 34023981

RE:A friend recommended me to this stock

RE:A friend recommended me to this stock   Clearly the issue with lxg is their inability to procure sales in any area that the product supposedly has value in.  They've failed to get the FDA approval they've been hunting for years now, no vets are jumping on buying their equipment. And that extends to the food and defence areas as well. 
     The hiring of 4 sales people months ago followed by paying Lavoie 18 k / month for their supposed "expertise " in this market has been fruitless . So what we have here Is the ongoing story of all the potential , the benefits, the multiple industries it can serve, the clear need for the science etc but the problem continues to be the inability to find any buyers .  When we ask why the excuses are piled up one after another.  Vets take a long process.  The FDA has never seen such complexities in a product. We are testing with the defence department but they'll take a long time to decide.  And on and on. 
        Every step that was supposed to move things forward has fine the opposite.  I think building these machines in house has left holes in reliability and performance creating more doubt and buyer resistance.   Broken promises on timelines have dissuaded investors and even their initial management people have left for other companies.  So essentially it's a matter of whether you believe these are all hiccups and will be overcome shortly, or if it's all a bunch of hype that isn't nearly as prolific as the Doctor wiyld have people believe.  No one actually knows the answer so it's a true spec stock that can go way up or down to zippo.  See what your research concludes 
<< Previous
Bullboard Posts
Next >>